Whole genome sequencing for drug resistance determination in .

Shaheed V Omar, Lavania Joseph, Halima M Said, Farzana Ismail, Nabila Ismail, Thabisile L Gwala, Nazir A Ismail
Author Information
  1. Shaheed V Omar: Centre for Tuberculosis, World Health Organization TB Supranational Reference Laboratory Network, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ORCID
  2. Lavania Joseph: Centre for Tuberculosis, World Health Organization TB Supranational Reference Laboratory Network, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ORCID
  3. Halima M Said: Centre for Tuberculosis, World Health Organization TB Supranational Reference Laboratory Network, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ORCID
  4. Farzana Ismail: Centre for Tuberculosis, World Health Organization TB Supranational Reference Laboratory Network, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ORCID
  5. Nabila Ismail: Centre for Tuberculosis, World Health Organization TB Supranational Reference Laboratory Network, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ORCID
  6. Thabisile L Gwala: Centre for Tuberculosis, World Health Organization TB Supranational Reference Laboratory Network, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ORCID
  7. Nazir A Ismail: Centre for Tuberculosis, World Health Organization TB Supranational Reference Laboratory Network, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ORCID

Abstract

South Africa remains challenged with a high tuberculosis burden accompanied by an increase in drug resistant cases. We assessed the use of the Illumina MiSeq, a next-generation sequencing platform for whole genome sequencing, followed by bioinformatic analysis using a commercial software package to determine resistance to selected drugs used for treatment in our setting. Whole genome sequencing shows potential as a diagnostic platform for the detection of drug resistance in with the provision of information for several drugs simultaneously.

References

  1. Int J Tuberc Lung Dis. 2006 Jul;10(7):802-7 [PMID: 16848344]
  2. J Clin Microbiol. 2007 Jan;45(1):76-80 [PMID: 17093022]
  3. PLoS Med. 2009 Feb 10;6(2):e2 [PMID: 19209951]
  4. Antimicrob Agents Chemother. 2010 Mar;54(3):1022-8 [PMID: 20038615]
  5. Lancet. 2010 May 22;375(9728):1830-43 [PMID: 20488523]
  6. Antimicrob Agents Chemother. 2011 Dec;55(12):5718-22 [PMID: 21930879]
  7. Nat Rev Microbiol. 2012 Sep;10(9):599-606 [PMID: 22864262]
  8. J Clin Microbiol. 2012 Nov;50(11):3732-4 [PMID: 22895034]
  9. J Clin Microbiol. 2012 Dec;50(12):3831-7 [PMID: 22972833]
  10. Emerg Infect Dis. 2013 Mar;19(3):449-55 [PMID: 23622714]
  11. N Engl J Med. 2013 Jul 18;369(3):290-2 [PMID: 23863072]
  12. BMC Med. 2013 Aug 29;11:190 [PMID: 23987891]
  13. Nat Genet. 2013 Oct;45(10):1183-9 [PMID: 23995135]
  14. PLoS One. 2013 Aug 23;8(8):e70919 [PMID: 24058399]
  15. Antimicrob Agents Chemother. 2014 May;58(5):2979-81 [PMID: 24590481]
  16. Int J Tuberc Lung Dis. 2015 Feb;19(2):185-90 [PMID: 25574917]
  17. J Clin Microbiol. 2015 Jun;53(6):1908-14 [PMID: 25854485]
  18. Genome Med. 2015 May 27;7(1):51 [PMID: 26019726]
  19. Lancet Infect Dis. 2015 Oct;15(10):1193-1202 [PMID: 26116186]
  20. Ther Adv Infect Dis. 2016 Apr;3(2):47-62 [PMID: 27034776]
  21. Clin Microbiol Infect. 2017 Mar;23(3):167-172 [PMID: 27664776]
  22. Clin Microbiol Infect. 2017 Mar;23(3):161-166 [PMID: 27789378]
  23. Microb Drug Resist. 2017 Dec;23(8):1045-1052 [PMID: 28447869]
  24. Lancet Infect Dis. 2018 Jun;18(6):675-683 [PMID: 29574065]

Word Cloud

Created with Highcharts 10.0.0sequencingdruggenomeresistanceplatformdrugsWholeSouthAfricaremainschallengedhightuberculosisburdenaccompaniedincreaseresistantcasesassesseduseIlluminaMiSeqnext-generationwholefollowedbioinformaticanalysisusingcommercialsoftwarepackagedetermineselectedusedtreatmentsettingshowspotentialdiagnosticdetectionprovisioninformationseveralsimultaneouslydetermination

Similar Articles

Cited By (5)